RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
45.17
+0.36 (0.80%)
Nov 21, 2024, 2:49 PM EST - Market open
RxSight Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 1,821 | 1,446 | 351 | 308 | - | - | |
Market Cap Growth | 97.32% | 311.68% | 14.14% | - | - | - | |
Enterprise Value | 1,580 | 1,317 | 284 | 185 | - | - | |
Last Close Price | 44.81 | 40.32 | 12.67 | 11.25 | - | - | |
PS Ratio | 13.19 | 16.23 | 7.17 | 13.62 | - | - | |
PB Ratio | 6.51 | 9.02 | 3.91 | 2.23 | - | - | |
P/TBV Ratio | 7.07 | 9.02 | 3.91 | 2.23 | - | - | |
EV/Sales Ratio | 12.32 | 14.79 | 5.79 | 8.17 | - | - | |
Debt / Equity Ratio | 0.04 | 0.02 | 0.50 | 0.33 | -0.40 | -0.06 | |
Asset Turnover | 0.52 | 0.54 | 0.29 | 0.15 | 0.14 | - | |
Inventory Turnover | 1.99 | 2.19 | 2.42 | 2.22 | 1.67 | - | |
Quick Ratio | 11.60 | 7.05 | 6.77 | 14.82 | 6.19 | 9.63 | |
Current Ratio | 12.67 | 8.06 | 7.81 | 15.92 | 7.03 | 10.67 | |
Return on Equity (ROE) | -13.99% | -38.85% | -58.52% | -159.76% | - | - | |
Return on Assets (ROA) | -9.92% | -18.82% | -23.08% | -22.49% | -20.96% | - | |
Return on Capital (ROIC) | -10.78% | -20.99% | -24.88% | -48.29% | - | - | |
Earnings Yield | -1.68% | -3.36% | -19.01% | -15.82% | - | - | |
FCF Yield | -1.49% | -3.21% | -17.44% | -15.16% | - | - | |
Buyback Yield / Dilution | -16.36% | -24.56% | -103.02% | -146.28% | 73.12% | - | |
Total Shareholder Return | -16.36% | -24.56% | -103.02% | -146.28% | 73.12% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.